Clirophtha performs phase I trials in specialized French sites with high recruitment potential.
Clirophtha has the capabilities to perform the following types of studies:
First administration in human.
Ocular and systemic safety.
Ocular and systemic pharmacokinetics/pharmacodynamics.
Multiple dose tolerance.
Bioavailability.
Bioequivalence.
Dose finding.
Phase II-IV trials
Clirophtha's experience in the field of ophthalmology enables us to maintain a network of highly motivated investigators for clinical research throughout Europe.